About Thomas Struengmann & family
  • Thomas Struengmann and twin brother Andreas were early backers of German firm BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.
  • The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.
  • The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.
  • In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.
Wealth History
HOVER TO REVEAL NET WORTH BY YEAR

Forbes Lists

Personal Stats
Age
74
Source of Wealth
Pharmaceuticals, Self Made
Residence
Tegernsee, Germany
Citizenship
Germany
Marital Status
Married
Children
4
Education
Master of Business Administration, University of Augsburg; Master of Business Administration, University of Augsburg
Did you know
After obtaining a business degree from the University of Augsburg, Thomas worked as a marketing manager for Schering-Plough.
Like his brother, an identical twin, he is said to be an accomplished golfer and likes to ski. He reportedly collects modern art and Swiss watches.
Related People & Companies
Ugur Sahin
Ugur Sahin
Related by financial asset: BioNTech Sponsored ADR
View Profile
Germany
Germany
Citizen of Germany
View Profile
Martine Rothblatt
Martine Rothblatt
Related by origin of wealth: Pharmaceuticals
View Profile
Dilip Shanghvi & family
Dilip Shanghvi & family
Related by origin of wealth: Pharmaceuticals
View Profile
Setiawan family
Setiawan family
Related by origin of wealth: Pharmaceuticals
View Profile

More on Forbes

5 minutes ago

Is Leadership an Art or a Science?

Is leadership really a science? Can it be broken down into hard-and-fast laws that work every time? Or is it something more ambiguous and amorphous.